ASND: Ascendis Pharma A Financial Statements
Balance sheet, income statement, and cash flow statements for Ascendis Pharma A (ASND).
$7.92B Market Cap.
ASND Market Cap. (MRY)
ASND Shares Outstanding (MRY)
ASND Assets (MRY)
Total Assets
$1.18B
Total Liabilities
$1.29B
Total Investments
$13.57M
ASND Income (MRY)
Revenue
$363.64M
Net Income
-$378.08M
Operating Expense
$598.15M
ASND Cash Flow (MRY)
CF Operations
-$306.20M
CF Investing
$6.88M
CF Financing
$443.93M
ASND Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $1,179,495,000 (42.87%) | $825,587,000 (-24.24%) | $1,089,738,000 (0.44%) | $1,084,921,000 (10.73%) |
Assets Current | $1,060,861,000 (50.96%) | $702,721,000 (-23.90%) | $923,471,000 (14.59%) | $805,886,000 (8.88%) |
Assets Non-Current | $118,634,000 (-3.44%) | $122,866,000 (-26.10%) | $166,267,000 (-40.41%) | $279,035,000 (16.43%) |
Goodwill & Intangible Assets | $4,028,000 (-8.85%) | $4,419,000 (-8.47%) | $4,828,000 (-8.42%) | $5,272,000 (-7.78%) |
Shareholders Equity | -$105,706,000 (27.45%) | -$145,697,000 (-155.32%) | $263,348,000 (-70.20%) | $883,635,000 (5.36%) |
Property Plant & Equipment Net | $98,714,000 (-10.77%) | $110,634,000 (-14.30%) | $129,095,000 (2.42%) | $126,049,000 (16.59%) |
Cash & Equivalents | $559,543,000 (42.68%) | $392,164,000 (-11.83%) | $444,767,000 (-0.34%) | $446,267,000 (-23.65%) |
Accumulated Other Comprehensive Income | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Deferred Revenue | $5,936,000 (-16.78%) | $7,133,000 (-49.81%) | $14,213,000 (155.40%) | $5,565,000 (1433.06%) |
Total Investments | $13,575,000 (4.74%) | $12,961,000 (-95.96%) | $321,112,000 (-15.87%) | $381,703,000 (47.53%) |
Investments Current | $0 (0%) | $7,275,000 (-97.50%) | $290,688,000 (23.28%) | $235,797,000 (75.60%) |
Investments Non-Current | $13,575,000 (138.74%) | $5,686,000 (-81.31%) | $30,424,000 (-79.15%) | $145,906,000 (17.24%) |
Inventory | $295,609,000 (41.49%) | $208,931,000 (59.89%) | $130,673,000 (73.29%) | $75,405,000 (0%) |
Trade & Non-Trade Receivables | $177,982,000 (211.71%) | $57,098,000 (114.15%) | $26,663,000 (10.63%) | $24,101,000 (176.42%) |
Trade & Non-Trade Payables | $96,394,000 (1.93%) | $94,566,000 (-6.40%) | $101,032,000 (70.04%) | $59,417,000 (171.35%) |
Accumulated Retained Earnings (Deficit) | -$113,855,000 (25.80%) | -$153,446,000 (-160.02%) | $255,673,000 (-70.81%) | $875,989,000 (5.35%) |
Tax Assets | $1,775,000 (121.32%) | $802,000 (-9.17%) | $883,000 (-1.12%) | $893,000 (0%) |
Tax Liabilities | $8,480,000 (4.32%) | $8,129,000 (48.07%) | $5,490,000 (2672.73%) | $198,000 (-34.22%) |
Total Debt | $856,616,000 (32.96%) | $644,265,000 (26.73%) | $508,377,000 (384.35%) | $104,961,000 (14.12%) |
Debt Current | $0 (0%) | $0 (0%) | $0 (0%) | $6,995,000 (1.98%) |
Debt Non-Current | $856,616,000 (32.96%) | $644,265,000 (26.73%) | $508,377,000 (418.93%) | $97,966,000 (15.10%) |
Total Liabilities | $1,285,201,000 (32.32%) | $971,284,000 (17.53%) | $826,390,000 (310.56%) | $201,286,000 (42.67%) |
Liabilities Current | $907,863,000 (23.27%) | $736,509,000 (2.75%) | $716,777,000 (614.23%) | $100,356,000 (90.05%) |
Liabilities Non-Current | $377,338,000 (60.72%) | $234,775,000 (114.19%) | $109,613,000 (8.60%) | $100,930,000 (14.33%) |
ASND Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $363,641,000 (36.34%) | $266,718,000 (421.20%) | $51,174,000 (557.93%) | $7,778,000 (11.87%) |
Cost of Revenue | $44,258,000 (-0.31%) | $44,395,000 (265.78%) | $12,137,000 (244.51%) | $3,523,000 (0%) |
Selling General & Administrative Expense | $291,142,000 (10.11%) | $264,410,000 (19.52%) | $221,227,000 (38.11%) | $160,180,000 (108.92%) |
Research & Development Expense | $307,004,000 (-25.75%) | $413,454,000 (8.91%) | $379,624,000 (28.31%) | $295,867,000 (13.40%) |
Operating Expenses | $598,146,000 (-11.76%) | $677,864,000 (12.82%) | $600,851,000 (31.75%) | $456,047,000 (35.10%) |
Interest Expense | $100,027,000 (127.00%) | $44,065,000 (-12.72%) | $50,487,000 (1190.90%) | $3,911,000 (-95.16%) |
Income Tax Expense | $4,843,000 (-33.68%) | $7,303,000 (35.82%) | $5,377,000 (1565.12%) | -$367,000 (-67.58%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$378,084,000 (21.47%) | -$481,447,000 (17.45%) | -$583,194,000 (-52.04%) | -$383,577,000 (8.44%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$378,084,000 (21.47%) | -$481,447,000 (17.45%) | -$583,194,000 (-52.04%) | -$383,577,000 (8.44%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$378,084,000 (21.47%) | -$481,447,000 (17.45%) | -$583,194,000 (-52.04%) | -$383,577,000 (8.44%) |
Weighted Average Shares | $57,891,570 (2.85%) | $56,287,060 (0.38%) | $56,071,793 (2.37%) | $54,771,763 (8.21%) |
Weighted Average Shares Diluted | $57,891,570 (2.85%) | $56,287,060 (0.38%) | $56,071,793 (2.37%) | $54,771,763 (8.21%) |
Earning Before Interest & Taxes (EBIT) | -$273,214,000 (36.47%) | -$430,079,000 (18.44%) | -$527,330,000 (-38.76%) | -$380,033,000 (-12.33%) |
Gross Profit | $319,383,000 (43.66%) | $222,323,000 (469.52%) | $39,037,000 (817.44%) | $4,255,000 (-38.80%) |
Operating Income | -$278,763,000 (38.81%) | -$455,541,000 (18.92%) | -$561,814,000 (-24.35%) | -$451,792,000 (-36.65%) |
ASND Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | $6,876,000 (-97.60%) | $286,474,000 (364.06%) | $61,732,000 (155.83%) | -$110,579,000 (62.03%) |
Net Cash Flow from Financing | $443,929,000 (230.57%) | $134,292,000 (-66.15%) | $396,773,000 (12.92%) | $351,387,000 (-41.69%) |
Net Cash Flow from Operations | -$306,197,000 (34.48%) | -$467,361,000 (5.72%) | -$495,699,000 (-18.69%) | -$417,649,000 (-53.80%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $144,608,000 (410.35%) | -$46,595,000 (-25.28%) | -$37,194,000 (78.97%) | -$176,841,000 (-543.18%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | -$10,187,000 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $7,353,000 (-97.45%) | $288,865,000 (333.17%) | $66,686,000 (187.56%) | -$76,158,000 (72.28%) |
Capital Expenditure | -$477,000 (80.05%) | -$2,391,000 (51.74%) | -$4,954,000 (79.56%) | -$24,234,000 (-46.89%) |
Issuance (Repayment) of Debt Securities | $122,793,000 (-2.40%) | $125,818,000 (-74.68%) | $496,925,000 (7829.43%) | -$6,429,000 (-34.67%) |
Issuance (Purchase) of Equity Shares | $321,136,000 (3022.07%) | $10,286,000 (110.27%) | -$100,152,000 (-127.99%) | $357,816,000 (-41.09%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $22,771,000 (479.01%) | -$6,008,000 (-116.83%) | $35,694,000 (-7.51%) | $38,591,000 (172.14%) |
Share Based Compensation | $95,512,000 (43.28%) | $66,660,000 (3.86%) | $64,180,000 (-3.97%) | $66,830,000 (25.69%) |
Depreciation Amortization & Accretion | $17,714,000 (-6.33%) | $18,911,000 (5.31%) | $17,958,000 (16.68%) | $15,391,000 (62.90%) |
ASND Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 87.80% (5.28%) | 83.40% (9.31%) | 76.30% (39.49%) | 54.70% (-45.30%) |
Profit Margin | -104.00% (42.38%) | -180.50% (84.16%) | -1139.60% (76.89%) | -4931.60% (18.15%) |
EBITDA Margin | -70.30% (54.41%) | -154.20% (84.51%) | -995.40% (78.77%) | -4688.10% (0.89%) |
Return on Average Equity (ROAE) | 198.40% (101.33%) | -14914.70% (-12658.51%) | -116.90% (-156.36%) | -45.60% (23.36%) |
Return on Average Assets (ROAA) | -39.40% (28.62%) | -55.20% (-20.00%) | -46.00% (-22.99%) | -37.40% (28.35%) |
Return on Sales (ROS) | -75.10% (53.41%) | -161.20% (84.36%) | -1030.50% (78.91%) | -4886.00% (-0.41%) |
Return on Invested Capital (ROIC) | -66.30% (-4.91%) | -63.20% (-6.22%) | -59.50% (17.36%) | -72.00% (44.06%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -20.24 (-52.66%) | -13.26 (-20.10%) | -11.04 (34.73%) | -16.91 (-2.39%) |
Price to Sales Ratio (P/S) | 21.04 (-12.05%) | 23.92 (-80.98%) | 125.79 (-84.91%) | 833.66 (-16.26%) |
Price to Book Ratio (P/B) | -71.94 (-60.36%) | -44.86 (-280.44%) | 24.86 (244.70%) | 7.21 (-16.10%) |
Debt to Equity Ratio (D/E) | -12.16 (-82.39%) | -6.67 (-312.43%) | 3.14 (1276.32%) | 0.23 (35.71%) |
Earnings Per Share (EPS) | -6.53 (23.63%) | -8.55 (17.79%) | -10.4 (-48.57%) | -7 (15.46%) |
Sales Per Share (SPS) | 6.54 (24.27%) | 5.26 (442.22%) | 0.97 (503.11%) | 0.16 (-4.17%) |
Free Cash Flow Per Share (FCFPS) | -5.3 (36.53%) | -8.35 (6.53%) | -8.93 (-10.67%) | -8.07 (-41.77%) |
Book Value Per Share (BVPS) | -1.83 (29.44%) | -2.59 (-155.10%) | 4.7 (-70.89%) | 16.13 (-2.64%) |
Tangible Assets Book Value Per Share (TABVPS) | 20.3 (39.18%) | 14.59 (-24.60%) | 19.35 (-1.84%) | 19.71 (2.43%) |
Enterprise Value Over EBIT (EV/EBIT) | -28 (-75.00%) | -16 (-33.33%) | -12 (20.00%) | -15 (21.05%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -30.41 (-85.25%) | -16.42 (-28.74%) | -12.75 (19.43%) | -15.83 (20.01%) |
Asset Turnover | 0.38 (23.86%) | 0.31 (665.00%) | 0.04 (400.00%) | 0.01 (-11.11%) |
Current Ratio | 1.17 (22.54%) | 0.95 (-25.93%) | 1.29 (-83.96%) | 8.03 (-42.71%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$306,674,000 (34.72%) | -$469,752,000 (6.17%) | -$500,653,000 (-13.30%) | -$441,883,000 (-53.41%) |
Enterprise Value (EV) | $8,094,452,135 (7.92%) | $7,500,754,314 (8.54%) | $6,910,727,998 (5.37%) | $6,558,845,548 (-17.36%) |
Earnings Before Tax (EBT) | -$373,241,000 (21.28%) | -$474,144,000 (17.94%) | -$577,817,000 (-50.50%) | -$383,944,000 (8.40%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$255,500,000 (37.86%) | -$411,168,000 (19.28%) | -$509,372,000 (-39.69%) | -$364,642,000 (-10.87%) |
Invested Capital | $564,677,000 (67.68%) | $336,760,000 (-22.00%) | $431,743,000 (-32.33%) | $637,987,000 (48.81%) |
Working Capital | $152,998,000 (552.82%) | -$33,788,000 (-116.35%) | $206,694,000 (-70.70%) | $705,530,000 (2.65%) |
Tangible Asset Value | $1,175,467,000 (43.15%) | $821,168,000 (-24.31%) | $1,084,910,000 (0.49%) | $1,079,649,000 (10.84%) |
Market Capitalization | $7,920,891,497 (9.08%) | $7,261,844,740 (4.27%) | $6,964,736,821 (-3.82%) | $7,241,666,357 (-17.63%) |
Average Equity | -$190,584,500 (-6004.10%) | $3,228,000 (-99.35%) | $498,889,500 (-40.74%) | $841,875,750 (19.57%) |
Average Assets | $958,520,000 (9.89%) | $872,224,250 (-31.15%) | $1,266,809,750 (23.37%) | $1,026,828,750 (28.04%) |
Invested Capital Average | $411,842,750 (-39.51%) | $680,812,500 (-23.15%) | $885,881,250 (67.80%) | $527,953,500 (100.80%) |
Shares | 57,535,349 (-0.21%) | 57,656,568 (1.10%) | 57,027,240 (5.94%) | 53,829,379 (2.11%) |
